| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2000054 | HB0017注射液 | HB0017 | Injection | Biological Products(1) | New Drug Application | 2020-04-01 | 华博生物医药技术（上海）有限公司 | Huabo Biopharm Co Ltd | In Review | 2020-03-31 | view |
| CXSL2000081 | HB0017注射液 | HB0017 | Injection | Biological Products(1) | New Drug Application | 2020-05-06 | 华博生物医药技术（上海）有限公司 | Huabo Biopharm Co Ltd | In Review | 2020-05-01 | view |
| CXSL2000076 | HB0017注射液 | HB0017 | Injection | Biological Products(1) | New Drug Application | 2020-05-06 | 华博生物医药技术（上海）有限公司 | Huabo Biopharm Co Ltd | In Review | 2020-05-01 | view |
| CXSB2300029 | HB0017注射液 | HB0017 | Injection | Biological Products(1) | Supplementary Application | 2023-03-31 | view | ||||
| CXSL2300533 | HB0017注射液 | HB0017 | Injection | Biological Products(1) | New Drug Application | 2023-08-02 | Huabo Biopharm Co Ltd | view | |||
| CXSB2300122 | HB0017注射液 | HB0017 | Injection | Biological Products(1) | Supplementary Application | 2023-11-04 | view | ||||
| CXSL2300840 | HB0017注射液 | HB0017 | Injection | Biological Products(1) | New Drug Application | 2023-12-06 | view | ||||
| CXSL2400749 | HB0017注射液 | HB0017 | Injection | Biological Products(1) | New Drug Application | 2024-11-05 | view |